Head of U.S. Health Economics & Value Assessment (HEVA)
Sanofi
About this role
The Head of U.S. Health Economics & Value Assessment (HEVA) is a senior strategic and scientific leader responsible for shaping and executing the U.S. HEVA strategy for Sanofi’s Specialty Care portfolio. The role translates global evidence into U.S.-specific evidence and dissemination, leads the U.S. HEVA team, and serves as a market-facing thought leader to influence pricing, access, and policy outcomes across the product lifecycle.
Skills
Qualifications
About Sanofi
sanofi.comSanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.
Recent company news
Fierce PharmaSanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
14 hours ago
Fierce BiotechTeva's $400M Blackstone deal to fund Sanofi-partnered IBD drug
13 hours ago
Endpoints NewsBlackstone to support Teva on Sanofi-partnered TL1A with $400M
14 hours ago
Simply Wall StreetSanofi Rumored Bid And Regulatory Shifts Reframe Ocular Therapeutix Valuation
11 hours ago
Law360Sanofi Gets Approval For Interlocutory Appeal In Taxotere MDL
23 hours ago
About Sanofi
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Sanofi.
Salary
$259k – $374k
per year
More jobs at Sanofi
Similar Jobs
Vice President, Health Economics and Outcomes Research
Crinetics Pharmaceuticals
Health Economics & Payer Evidence Lead
American Association of Physicists in Medicine
Director, Field Health Economics & Outcomes Research (HEOR)
Nuvalent, Inc.
AVP, Health Economics and Outcomes Research
Inovalon
Director, Global Health Economics & Outcomes Research (HEOR)
Dyne Therapeutics
Director, Global Health Economics Lead, Oncology Business Unit
Takeda Pharmaceutical Company